Glutathione is an antioxidant produced in cells and its levels typically decline with age. Oral administration of glutathione results in variable reductions in melanin levels, according to a study. However, intravenous glutathione may cause anaphylaxis (a life-threatening allergic reaction) and hepatotoxicity (liver damage), with risks further heightened by lack of standardised dosing protocols.